Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice
about
An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive ImmunityHuman H-ficolin inhibits replication of seasonal and pandemic influenza A virusesSerum amyloid P is a sialylated glycoprotein inhibitor of influenza A virusesNatural antibody and complement mediate neutralization of influenza virus in the absence of prior immunitySurfactant protein-D and pulmonary host defenseThe role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia.Innate immunity to influenza virus: implications for future therapyRecognition of Mannosylated Ligands and Influenza A Virus by Human Surfactant Protein D: Contributions of an Extended Site and Residue 343 † , ‡Molecular Mechanisms of Inhibition of Influenza by Surfactant Protein D Revealed by Large-Scale Molecular Dynamics SimulationSurfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergensAssessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitroStructural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants.Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein DAntiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.Arginine-rich histones have strong antiviral activity for influenza A virusesDoes Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin.The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D bindingSynergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection.A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.Chronic exercise reduces illness severity, decreases viral load, and results in greater anti-inflammatory effects than acute exercise during influenza infection.Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambsLack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection.Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?Involvement of the mannose receptor in infection of macrophages by influenza virus.Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity.The role of neutrophils during mild and severe influenza virus infections of mice.Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response.Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosisMonoclonal antibody-assisted structure-function analysis of the carbohydrate recognition domain of surfactant protein DContributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells.N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGNDeficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa.
P2860
Q21131225-078DA165-2978-4990-8E34-1954DABA2B31Q24294554-48409FE8-1E78-4EE3-8AC4-59C9D1E60997Q24337745-9CBDC7BD-1A51-434B-96EF-B062D88F99AEQ24672388-083AD8D4-0F96-4875-93EE-ACA6417A102AQ24791368-EFACE5BA-AE39-401E-B3EC-AB08E491F8FFQ24816691-EED28505-AD64-4F63-9E30-10C175C5399CQ27489605-AE589206-FE9A-4C83-87C5-44F18FFC5239Q27653971-B6B715BF-83CE-4364-B24D-B530F05FDF49Q27680598-328B2EBB-61D9-4BED-A94A-098CC0E88D06Q28350208-160CD461-9D85-438B-877F-D0A728BF702CQ28740380-FBFE93C1-3880-4D10-8C8E-D91CEC614A69Q30336387-13BB863E-4D05-4BE1-A753-953B7613D6E2Q30360290-7177E98D-15F5-4DF9-BFF8-DB2DE1DF769DQ30361068-6E3C5A2C-C41F-4C44-B5B1-64DFEFAD2195Q30372223-0FA9EEA2-1D54-43C3-A651-43DBB58A11D3Q30374098-CB42725E-6604-476C-AB92-E2E6F708DA1BQ30376265-43340B07-30C3-429C-88C4-B518F28CFB8FQ30384213-DF3F791F-40BA-438F-8814-59FF728E7F2FQ30399355-AFFDAAB2-829A-4D0E-BF71-E5E32211DCACQ30399889-50621728-D3EC-44E7-AB7E-E2A878A7C8CFQ30399993-118E9310-15AE-4E74-97CD-9F6294CB3644Q30409432-56CE6D36-0946-4D96-A1E3-62DF77A80CD3Q30416451-BF4E13F1-0EB1-4907-9CC3-C6E34BF2400CQ33616654-C765A564-B5D8-42C3-8B5B-E26C05060673Q33637378-424FCFC4-D8B8-4875-B9A4-003437B89B02Q33711962-674F2B43-FEB1-4A50-928E-E5BE3D4B0E11Q33779595-A063940C-9BA7-4668-8121-C9C86D488B55Q33783669-572E711A-C75B-4E6D-9160-0D4873C81CDFQ33787102-B0AC8383-2080-4C9C-8E75-968260FAE055Q33843560-42DF1356-E155-41A7-93CA-E8A8D30ECA27Q33851748-6E2136B8-31B4-42B8-AD9B-B018E85074F9Q33857510-E58DDA77-2F93-4E27-A2C1-9B1ABA8966A1Q33920480-DB278065-7623-4F92-94A0-AE85C6BD7E15Q33964051-47D12DEC-88D0-4BB2-8410-06C20D124299Q34007073-C4481FC0-720E-4746-AE94-E502F87918E3Q34180763-263D7D08-791B-49ED-B611-360C9A387CDCQ34181880-25CE6059-D4AA-4DF0-9D1C-912E268695FFQ34592745-FC622C45-FB4A-45AB-B675-F57FDCD55F26Q34742902-CFB76C5E-22D7-4FCF-8380-70B15C244381Q34767098-59B92EDE-5217-43E0-AC9B-5B41322D472F
P2860
Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Collectin-mediated antiviral h ...... luenza virus infection of mice
@ast
Collectin-mediated antiviral h ...... luenza virus infection of mice
@en
type
label
Collectin-mediated antiviral h ...... luenza virus infection of mice
@ast
Collectin-mediated antiviral h ...... luenza virus infection of mice
@en
prefLabel
Collectin-mediated antiviral h ...... luenza virus infection of mice
@ast
Collectin-mediated antiviral h ...... luenza virus infection of mice
@en
P2093
P2860
P1433
P1476
Collectin-mediated antiviral h ...... luenza virus infection of mice
@en
P2093
P2860
P304
P407
P577
1997-11-01T00:00:00Z